Scholar Rock Holding SRRK
NASDAQ SRRK
$55.46 -0.48 (-0.86%)
As of: Sep 4, 2026 · 2:28 PM EDT

Scholar Rock Holding (SRRK) Interest Expenses (2024 - 2026)

Scholar Rock Holding (SRRK) posted quarterly Interest Expenses of $2.4 million for Q1 2026, up 15.46% year-over-year from $2.1 million in Q1 2025, and down 17.06% quarter-over-quarter from $2.9 million in Q4 2025.

Analysis

Scholar Rock Holding (SRRK) Interest Expenses (2024 - 2026) Analysis & Trends

Scholar Rock Holding's Interest Expenses history runs 10 years deep, the most recent figure standing at $2.4 million for Q1 2026.

  • In Q1 2026, Interest Expenses rose 15.46% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $8.9 million (up 20.24% YoY), while the FY2025 annual figure was $185.5 million, down 36.69% from the prior year.
  • Interest Expenses for Q1 2026 stood at $2.4 million, down from $2.9 million in the prior quarter.
  • The five-year high for Interest Expenses was $159.6 million in Q3 2025, with the low at $748000.0 in Q2 2022.
  • The 5-year median for Interest Expenses is $2.4 million (2026), against an average of $20.6 million.
  • The sharpest annual moves came in 2022 and 2025: Interest Expenses slumped 98.4% in 2022, then soared 5280.62% in 2025.
  • Scholar Rock Holding's Interest Expenses stood at $1.7 million in 2022, then grew by 19.6% to $2.0 million in 2023, then slipped by 19.1% to $1.6 million in 2024, then soared by 76.89% to $2.9 million in 2025, then dropped by 17.06% to $2.4 million in 2026.
  • Business Quant data shows SRRK's Interest Expenses at $2.4 million in Q1 2026, $2.9 million in Q4 2025, and $159.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -1.00 Mn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn -
5 Revolution Medicines 44.04 Bn 44.04 Bn - 23.78 Mn
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn - 93.62 Mn
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn 20.27 Mn
10 Scholar Rock Holding 7.25 Bn 7.25 Bn - 4.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.52 Mn
Mar 31, 2026 2.30 Mn
Dec 31, 2025 2.53 Mn
Sep 30, 2025 1.33 Mn
Jun 30, 2025 1.21 Mn
Mar 31, 2025 1.82 Mn
Dec 31, 2024 1.65 Mn
Sep 30, 2024 1.74 Mn
Jun 30, 2024 1.72 Mn
Mar 31, 2024 1.73 Mn